Antifungal Efficacy, Safety, and Single-Dose Pharmacokinetics of LY303366, a Novel Echinocandin B, in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

LY303366 is a novel semisynthetic derivative of echinocandin B and a potent inhibitor of fungal (1,3)-β-d-glucan synthase. The antifungal efficacy and safety of LY303366 were investigated in treatment and prophylaxis of primary pulmonary aspergillosis due to Aspergillus fumigatus in persistently neu...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Petraitis, Vidmantas, Petraitiene, Ruta, Groll, Andreas H., Bell, Aaron, Callender, Diana P., Sein, Tin, Schaufele, Robert L., McMillian, Carl L., Bacher, John, Walsh, Thomas J.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1998
Teme:	Experimental Therapeutics
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105963/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9797223/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.11.2898
Oznake:	Označite Brez oznak, prvi označite!